PRVA
$22.10
Privia Health Group, Inc.
Recent News
Privia Health (PRVA): Buy, Sell, or Hold Post Q4 Earnings?
Privia Health has been treading water for the past six months, recording a small loss of 1.6% while holding steady at $22.55.
Privia Health’s EHR Cancer Screening Gains Put Value Based Story In Focus
Privia Health Group (NasdaqGS:PRVA) recently reported major progress in colorectal cancer screening outcomes tied to its EHR integrated patient outreach program. The program has been rolled out at national scale and is linked with screening rates that exceed key benchmarks. The results highlight measurable gains in preventive care that are being achieved through technology focused partnerships. For investors tracking Privia Health Group at a share price of $23.27, this news adds fresh...
BlackBarn Capital Builds Warby Parker Stake as the Direct-to-Consumer Eyewear Leader Expands Nationwide
BlackBarn Capital has raised its investment in Warby Parker, a direct-to-consumer eyewear brand recognized for its affordable frames and expanding network of stores. As Warby Parker opens more locations and adds vision services, investors are paying attention to whether its strong brand can drive lasting growth.
Privia Health price target raised to $33 from $31 at Truist
Truist analyst Jailendra Singh raised the firm’s price target on Privia Health (PRVA) to $33 from $31 and keeps a Buy rating on the shares after hosting management talks. The company noted that the sequential decline in FFS Practice Collections was driven by a higher concentration of specialists versus primary care and specific “retroactive” claims processing timing in the California and North Texas markets, also having suggested that averaging Q3 and Q4 results provides a more accurate represen
Vanquis Banking Group PLC (STU:PRVA) Full Year 2025 Earnings Call Highlights: A Return to ...
Vanquis Banking Group PLC (STU:PRVA) reports a significant turnaround with GBP8.3 million profit before tax, exceeding customer interest earning balances, and achieving substantial cost reductions.